Serum antibody levels after immunization with trivalent oral poliovirus vaccine. 1980

O Pollak, and D J Power, and P Bundred, and A C Joosting

The antibody titres to the polioviruses after three doses of trivalent oral poliovirus vaccine were assessed in 77 Coloured children aged 3-9 months. Neutralizing antibody titres of 1 in 10 or greater to all three types were found in 59 (77%) of all children. The remaining 18 children lacked demonstrable antibody to one or more of the polioviruses. Antibody to types 1 and 3 was most commonly lacking. The possible reasons for the failure of vaccination in so many children is discussed. Studies of the effect of further doses of vaccine on serum antibody levels are recommended.

UI MeSH Term Description Entries
D007115 Immunization Schedule Schedule giving optimum times usually for primary and/or secondary immunization. Immunization Schedules,Schedule, Immunization,Schedules, Immunization
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D011055 Poliovirus Vaccine, Oral A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed) Sabin Vaccine,Oral Poliovirus Vaccine,Vaccine, Oral Poliovirus,Vaccine, Sabin
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

O Pollak, and D J Power, and P Bundred, and A C Joosting
July 1977, Pediatrics,
O Pollak, and D J Power, and P Bundred, and A C Joosting
January 1976, Acta paediatrica Belgica,
O Pollak, and D J Power, and P Bundred, and A C Joosting
January 1992, Bulletin of the World Health Organization,
O Pollak, and D J Power, and P Bundred, and A C Joosting
September 1970, Acta paediatrica Scandinavica,
O Pollak, and D J Power, and P Bundred, and A C Joosting
February 1964, The New England journal of medicine,
O Pollak, and D J Power, and P Bundred, and A C Joosting
October 1964, JAMA,
O Pollak, and D J Power, and P Bundred, and A C Joosting
September 1962, Journal of bacteriology,
O Pollak, and D J Power, and P Bundred, and A C Joosting
June 1964, Pediatrics,
O Pollak, and D J Power, and P Bundred, and A C Joosting
March 1970, Pediatrics,
O Pollak, and D J Power, and P Bundred, and A C Joosting
November 1993, The Journal of infectious diseases,
Copied contents to your clipboard!